Halozyme Therapeutic (NQ: HALO )
53.60
+0.60
(+1.12%)
Streaming Delayed Price
Updated: 10:41 AM EDT, Oct 14, 2024
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
NASDAQ:HALO is showing good growth, while it is not too expensive.
September 19, 2024
(HALO) - Analyzing Halozyme Therapeutics's Short Interest
September 13, 2024
NASDAQ:HALO is not too expensive for the growth it is showing.
August 29, 2024
Top 2 Health Care Stocks That May Plunge In August
August 26, 2024
How Is The Market Feeling About Halozyme Therapeutics?
August 20, 2024
(HALO) - Analyzing Halozyme Therapeutics's Short Interest
August 01, 2024
Analyst Scoreboard: 14 Ratings For Halozyme Therapeutics
August 01, 2024
Avadel Pharmaceuticals Stock Sees RS Rating Jump to 82
August 06, 2024
3 Biotech Stocks on Track for 50% Returns (or More) by 2028
August 04, 2024
Beam Therapeutics Stock Earns RS Rating Jump To 85
July 24, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|